What is DAWN's dilution risk score?

DAWN has a latest available DilutionScore record of 16/100, categorized as low dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for DAWN, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for DAWN?

DilutionWatch tracks 25 SEC filing types for DAWN including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect DAWN shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For DAWN, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for DAWN tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for DAWN. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

DAWN Dilution Risk Score: 16/100 (LOW)

Score Breakdown

📋 Offering Ability

20

💰 Cash Runway

10

📊 Float Risk

20

⚠️ Warrant Exposure

15

🔄 Convertible Debt

15

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 0%

No significant dilution signals detected for DAWN.

🔔 Track DAWN — Get forecast alerts →

Market Data

Market Cap$2.22B

Shares Outstanding103.33M

Float71.35M

Cash$441.11M

Debt$2.79M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 16.6% shares (2026Q1 vs prior)

216 institutional holders · 101.09M shares

#1 BlackRock, Inc. 7.04M shares

#2 VANGUARD CAPITAL MANAGEMENT LLC 6.72M shares

#3 GLAZER CAPITAL, LLC 4.68M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

No current FINRA short-interest record is available for this ticker.

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2024-12-31

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual DAWN Dilution Snapshot

Day One Biopharmaceuticals Inc (DAWN) has a DilutionScore of 16/100, rated Low dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for DAWN: xbrl on 2024-12-31.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.